These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4679251)

  • 21. [Comparative study with tolbutamide and glibornuride for the diagnosis of latent diabetes mellitus].
    Wieser O; Iglauer E
    Wien Klin Wochenschr; 1972 Nov; 84(45):733-4. PubMed ID: 4634673
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug induced changes of the blood glucose lowering effect of oral hypoglycemic agents].
    Christensen LK; Kristensen M
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():116-36. PubMed ID: 4190079
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of phenylbutazone and tolbutamide in man.
    Szita M; Gachályi B; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):378-80. PubMed ID: 7450929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 25. Potentiation of the hypoglycaemic action of tolbutamide by different drugs.
    Mahfouz M; Abdel-Maguid R; el-Dakhakhny M
    Arzneimittelforschung; 1970 Jan; 20(1):120-2. PubMed ID: 5467602
    [No Abstract]   [Full Text] [Related]  

  • 26. [New hypoglycemic benzenesulfonamido-pyrimidines N-substituted 4- N-(2-pyrimidinyl) sulfonyl--phenylacetamides].
    Gutsche K; Schröder E; Rufer C; Loge O
    Arzneimittelforschung; 1974 Jul; 24(7):1028-39. PubMed ID: 4408077
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacokinetics and metabolite spectrum of glisoxepide in humans].
    Speck U; Mützel W; Kolb KH; Acksteiner B; Schulze PE
    Arzneimittelforschung; 1974 Mar; 24(0):404-9. PubMed ID: 4408089
    [No Abstract]   [Full Text] [Related]  

  • 28. Anti-diabetic agents.
    Biron CR
    RDH; 1995 May; 15(5):32-4. PubMed ID: 10332415
    [No Abstract]   [Full Text] [Related]  

  • 29. Duration of action and pharmacokinetics of the oral antidiabetic drug gliquidone in patients with non-insulin-dependent (type 2) diabetes mellitus.
    von Nicolai H; Brickl R; Eschey H; Greischel A; Heinzel G; König E; Limmer J; Rupprecht E
    Arzneimittelforschung; 1997 Mar; 47(3):247-52. PubMed ID: 9105542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 31. [Interaction of salicyl compounds and other non-steroidal anti-inflammatory agents: pharmacokinetic study of phenylbutazone-aspirin combination in man].
    Gaucher A; Netter P; Faure G; Tamisier JN; Pourel J; Maillard A; Royer RJ
    Rev Rhum Mal Osteoartic; 1976 Jun; 43(6):425-9. PubMed ID: 781789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride.
    Niemi M; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ; Kivistö KT
    Clin Pharmacol Ther; 2001 Apr; 69(4):194-200. PubMed ID: 11309547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interactions of gliclazide and other sulfonylureas in protein binding in vitro and in hypoglycemic effect in rats.
    Fujii T; Nakamura K; Furukawa H; Watanabe M; Kuwashima J; Miyazaki H; Kawashima K; Kuzuya T
    Arzneimittelforschung; 1983; 33(11):1535-7. PubMed ID: 6686448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic of glipentide (UR-661) by IV. administration on healthy and diabetic volunteers (author's transl)].
    Rimbau Barreras V; Uriach Marsal J; Pou Torelló JM
    Arch Farmacol Toxicol; 1976 Aug; 2(2):115-22. PubMed ID: 791156
    [No Abstract]   [Full Text] [Related]  

  • 36. [Glibornurid in treatment of diabetes mellitus].
    Rojszykowa E; Wrzesimski W
    Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sulfonylureas and diabetes mellitus].
    Ascaso JF
    Med Clin (Barc); 1983 Sep; 81(7):302-4. PubMed ID: 6645672
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug interactions with oral sulphonylurea hypoglycaemic drugs.
    Hansen JM; Christensen LK
    Drugs; 1977 Jan; 13(1):24-34. PubMed ID: 401727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protein binding of glisoxepide and its influence on the protein binding of phenprocoumon].
    Schlossmann K
    Arzneimittelforschung; 1974 Mar; 24(0):392-7. PubMed ID: 4408096
    [No Abstract]   [Full Text] [Related]  

  • 40. [Inhibitory effects of sulfonylureas (hypoglycemic agents) on the color reaction using oxidase].
    Sakoguchi T; Kitani Y; Kimura M; Hase A; Kobayashi K; Matsuoka A
    Rinsho Byori; 1982 May; 30(5):533-7. PubMed ID: 7131818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.